Vulnerability-Lookup

GHSA-R26F-V6J2-2H4J

Vulnerability from github – Published: 2021-12-02 00:00 – Updated: 2022-10-25 19:00

Details

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Severity

8.1 (High)


                  
                    CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Show details on source website

JSON

To clipboard

{
  "affected": [],
  "aliases": [
    "CVE-2020-10627"
  ],
  "database_specific": {
    "cwe_ids": [
      "CWE-284"
    ],
    "github_reviewed": false,
    "github_reviewed_at": null,
    "nvd_published_at": "2021-12-01T16:15:00Z",
    "severity": "HIGH"
  },
  "details": "Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.",
  "id": "GHSA-r26f-v6j2-2h4j",
  "modified": "2022-10-25T19:00:30Z",
  "published": "2021-12-02T00:00:37Z",
  "references": [
    {
      "type": "ADVISORY",
      "url": "https://nvd.nist.gov/vuln/detail/CVE-2020-10627"
    },
    {
      "type": "WEB",
      "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01"
    },
    {
      "type": "WEB",
      "url": "https://www.myomnipod.com/security-bulletins"
    }
  ],
  "schema_version": "1.4.0",
  "severity": [
    {
      "score": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N",
      "type": "CVSS_V3"
    }
  ]
}

CVE-2020-10627 (GCVE-0-2020-10627)

Vulnerability from cvelistv5 – Published: 2021-12-01 15:38 – Updated: 2024-08-04 11:06

Summary

Severity

7.3 (High)


                        
                          CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L

CWE

CWE-284 - Improper Access Control

Assigner

icscert icscert root

References

2 references

URL	Tags
https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01	x_refsource_MISC
https://www.myomnipod.com/security-bulletins	x_refsource_MISC

Impacted products

1 product

Vendor	Product	Version
Insulet	Omnipod Insulin Management System	Affected: 19191 Affected: 40160 Affected: ZXP425 Affected: ZXR425

Credits

Thirdwayv Inc. reported this vulnerability to Insulet

Show details on NVD website

JSON

To clipboard

{
  "containers": {
    "adp": [
      {
        "providerMetadata": {
          "dateUpdated": "2024-08-04T11:06:10.161Z",
          "orgId": "af854a3a-2127-422b-91ae-364da2661108",
          "shortName": "CVE"
        },
        "references": [
          {
            "tags": [
              "x_refsource_MISC",
              "x_transferred"
            ],
            "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01"
          },
          {
            "tags": [
              "x_refsource_MISC",
              "x_transferred"
            ],
            "url": "https://www.myomnipod.com/security-bulletins"
          }
        ],
        "title": "CVE Program Container"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Omnipod Insulin Management System",
          "vendor": "Insulet",
          "versions": [
            {
              "status": "affected",
              "version": "19191"
            },
            {
              "status": "affected",
              "version": "40160"
            },
            {
              "status": "affected",
              "version": "ZXP425"
            },
            {
              "status": "affected",
              "version": "ZXR425"
            }
          ]
        }
      ],
      "credits": [
        {
          "lang": "en",
          "value": "Thirdwayv Inc. reported this vulnerability to Insulet"
        }
      ],
      "descriptions": [
        {
          "lang": "en",
          "value": "Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "LOCAL",
            "availabilityImpact": "LOW",
            "baseScore": 7.3,
            "baseSeverity": "HIGH",
            "confidentialityImpact": "LOW",
            "integrityImpact": "HIGH",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "cweId": "CWE-284",
              "description": "CWE-284 Improper Access Control",
              "lang": "en",
              "type": "CWE"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2021-12-01T15:38:31.000Z",
        "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "shortName": "icscert"
      },
      "references": [
        {
          "tags": [
            "x_refsource_MISC"
          ],
          "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01"
        },
        {
          "tags": [
            "x_refsource_MISC"
          ],
          "url": "https://www.myomnipod.com/security-bulletins"
        }
      ],
      "source": {
        "advisory": "ICSMA-20-079-01",
        "discovery": "EXTERNAL"
      },
      "workarounds": [
        {
          "lang": "en",
          "value": "Insulet recommends patients using the affected products talk to their healthcare provider about the risks of continued use, including the possibility of changing to the latest model with increased cybersecurity protection.\nAdditionally, Insulet recommends all patients take the cybersecurity precautions indicated below.\n\n    Do not connect to or allow any third-party devices to be connected to or use any software not authorized by Insulet.\n    Maintain tight physical control of the pump and devices connected to the pump.\n    Be attentive to pump notifications, alarms, and alerts.\n    Immediately cancel any unintended boluses (a single dose of insulin administered all at once).\n    Monitor blood glucose levels closely and act as appropriate.\n    Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis or if you suspect insulin pump settings or insulin delivery has changed unexpectedly.\n\nInsulet has released additional patient-focused information: https://www.myomnipod.com/security-bulletins \n\nMore information is available regarding Insulet\u2019s product security and vulnerability management: https://www.myomnipod.com/product-security"
        }
      ],
      "x_generator": {
        "engine": "Vulnogram 0.0.9"
      },
      "x_legacyV4Record": {
        "CVE_data_meta": {
          "ASSIGNER": "ics-cert@hq.dhs.gov",
          "ID": "CVE-2020-10627",
          "STATE": "PUBLIC"
        },
        "affects": {
          "vendor": {
            "vendor_data": [
              {
                "product": {
                  "product_data": [
                    {
                      "product_name": "Omnipod Insulin Management System",
                      "version": {
                        "version_data": [
                          {
                            "version_affected": "=",
                            "version_value": "19191"
                          },
                          {
                            "version_affected": "=",
                            "version_value": "40160"
                          },
                          {
                            "version_affected": "=",
                            "version_value": "ZXP425"
                          },
                          {
                            "version_affected": "=",
                            "version_value": "ZXR425"
                          }
                        ]
                      }
                    }
                  ]
                },
                "vendor_name": "Insulet"
              }
            ]
          }
        },
        "credit": [
          {
            "lang": "eng",
            "value": "Thirdwayv Inc. reported this vulnerability to Insulet"
          }
        ],
        "data_format": "MITRE",
        "data_type": "CVE",
        "data_version": "4.0",
        "description": {
          "description_data": [
            {
              "lang": "eng",
              "value": "Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery."
            }
          ]
        },
        "generator": {
          "engine": "Vulnogram 0.0.9"
        },
        "impact": {
          "cvss": {
            "attackComplexity": "LOW",
            "attackVector": "LOCAL",
            "availabilityImpact": "LOW",
            "baseScore": 7.3,
            "baseSeverity": "HIGH",
            "confidentialityImpact": "LOW",
            "integrityImpact": "HIGH",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L",
            "version": "3.1"
          }
        },
        "problemtype": {
          "problemtype_data": [
            {
              "description": [
                {
                  "lang": "eng",
                  "value": "CWE-284 Improper Access Control"
                }
              ]
            }
          ]
        },
        "references": {
          "reference_data": [
            {
              "name": "https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01",
              "refsource": "MISC",
              "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01"
            },
            {
              "name": "https://www.myomnipod.com/security-bulletins",
              "refsource": "MISC",
              "url": "https://www.myomnipod.com/security-bulletins"
            }
          ]
        },
        "source": {
          "advisory": "ICSMA-20-079-01",
          "discovery": "EXTERNAL"
        },
        "work_around": [
          {
            "lang": "en",
            "value": "Insulet recommends patients using the affected products talk to their healthcare provider about the risks of continued use, including the possibility of changing to the latest model with increased cybersecurity protection.\nAdditionally, Insulet recommends all patients take the cybersecurity precautions indicated below.\n\n    Do not connect to or allow any third-party devices to be connected to or use any software not authorized by Insulet.\n    Maintain tight physical control of the pump and devices connected to the pump.\n    Be attentive to pump notifications, alarms, and alerts.\n    Immediately cancel any unintended boluses (a single dose of insulin administered all at once).\n    Monitor blood glucose levels closely and act as appropriate.\n    Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis or if you suspect insulin pump settings or insulin delivery has changed unexpectedly.\n\nInsulet has released additional patient-focused information: https://www.myomnipod.com/security-bulletins \n\nMore information is available regarding Insulet\u2019s product security and vulnerability management: https://www.myomnipod.com/product-security"
          }
        ]
      }
    }
  },
  "cveMetadata": {
    "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
    "assignerShortName": "icscert",
    "cveId": "CVE-2020-10627",
    "datePublished": "2021-12-01T15:38:31.000Z",
    "dateReserved": "2020-03-16T00:00:00.000Z",
    "dateUpdated": "2024-08-04T11:06:10.161Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.1"
}

Sightings

Author	Source	Type	Date	Other

Nomenclature

Seen: The vulnerability was mentioned, discussed, or observed by the user.
Confirmed: The vulnerability has been validated from an analyst's perspective.
Published Proof of Concept: A public proof of concept is available for this vulnerability.
Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
Not confirmed: The user expressed doubt about the validity of the vulnerability.
Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.

Detection rules are retrieved from Rulezet.

The MITRE ATT&CK techniques below are AI-generated suggestions, inferred from the description of the vulnerability by the CIRCL/vulnerability-attack-technique-classification-roberta-base model, served locally by ML-Gateway. They have not been verified by an analyst and are provided for guidance only.
The approach is described in our paper Mapping CVEs to MITRE ATT&CK Techniques: A Curated Gold-Set Classifier and the Limits of LLM-Assisted Label Expansion.
Browse all ATT&CK techniques and the vulnerabilities related to each.

Related by attack behaviour

Vulnerabilities whose description is nearest to this one in the vector space of the CIRCL/vulnerability-attack-technique-biencoder model. This is a similarity search over the bi-encoder space (plain cosine), not a classification, and it has no measured accuracy.